ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,321.41
0.25%
Dow Jones
39,872.99
0.17%
US Dollar vs MXN
16.5971
-0.15%
Brent Oil
81.845
-0.73%
Bitcoin
69,897.25
-0.33%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Seelos Therapeutics Inc (SEEL)

  7. Seelos Therapeutics Inc (SEEL) Noticias

SEEL

Seelos Therapeutics (SEEL)

Seelos Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SEEL
FechaHoraFuenteTítuloSímboloCompañía
21/05/202415:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
20/05/202415:16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SEELSeelos Therapeutics Inc
14/05/202407:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SEELSeelos Therapeutics Inc
06/03/202416:32Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SEELSeelos Therapeutics Inc
06/03/202415:50Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SEELSeelos Therapeutics Inc
01/03/202416:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
14/02/202415:50Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SEELSeelos Therapeutics Inc
06/02/202416:26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SEELSeelos Therapeutics Inc
02/02/202405:04Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SEELSeelos Therapeutics Inc
02/01/202407:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SEELSeelos Therapeutics Inc
27/12/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SEELSeelos Therapeutics Inc
18/12/202315:54Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SEELSeelos Therapeutics Inc
15/12/202315:06Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SEELSeelos Therapeutics Inc
04/12/202315:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SEELSeelos Therapeutics Inc
28/11/202315:03Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SEELSeelos Therapeutics Inc
29/06/202308:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SEELSeelos Therapeutics Inc
12/05/202315:06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SEELSeelos Therapeutics Inc
28/04/202305:23Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SEELSeelos Therapeutics Inc
12/04/202315:11Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:SEELSeelos Therapeutics Inc
31/03/202316:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SEELSeelos Therapeutics Inc
31/03/202315:09Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:SEELSeelos Therapeutics Inc
13/03/202315:12Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SEELSeelos Therapeutics Inc
10/03/202305:05Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SEELSeelos Therapeutics Inc
09/02/202311:00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SEELSeelos Therapeutics Inc
08/07/202215:59Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SEELSeelos Therapeutics Inc
04/05/202206:35TipRanksAnalysts Offer Insights on Healthcare Companies: Seelos Therapeutics (SEEL) and Masimo (MASI)NASDAQ:SEELSeelos Therapeutics Inc
12/04/202216:03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SEELSeelos Therapeutics Inc
11/03/202211:05TipRanksAnalysts Offer Insights on Healthcare Companies: Seelos Therapeutics (SEEL) and Leap Therapeutics (LPTX)NASDAQ:SEELSeelos Therapeutics Inc
24/01/202203:50TipRanksB.Riley Financial Thinks Seelos Therapeutics’ Stock is Going to RecoverNASDAQ:SEELSeelos Therapeutics Inc
27/12/202116:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:SEELSeelos Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SEEL

Su Consulta Reciente

NASDAQ
MSFT
Microsoft
FX
EURMXN
Euro vs MXN
NASDAQ
TSLA
Tesla
CCOM
OILBRENT
Brent Oil
USI
USTECH100
US Tech 100
CCOM
SILVER
SILVER
NYSE
KO
Coca Cola
AMEX
XLF
Financial Select Sector
NYSE
BAC
Bank of America
CCOM
US500
US 500
USOTC
BNPQY
BNP Paribas (QX)
AMEX
SPY
SPDR S&P 500
AMEX
XLE
Energy Select Sector SPDR
NYSE
MCD
McDonalds
CCOM
US30
US 30
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados